Details
This webinar presented a case of a patient with advanced-stage high-grade serous ovarian cancer whose comprehensive genomic profiling (CGP) testing revealed a BRCA1 mutation. Participants joined a molecular tumor board discussion to uncover additional key molecular findings, including an in-depth review of the homologous recombination deficiency (HRD) results. The session also reviewed potential hereditary cancer risk findings for the patient and discussed treatment and clinical trial implications.
Explore more case reviews from our Grand Rounds in Genomics Medicine sessions here.
Speaker
Erica Schnettler, Ph.D.
Associate Director, Medical Affairs for Oncology
Illumina
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
- Date & Time
- Feb 26, 2026
- 08:00 AM
- Presenter
- Erica Schnettler
- Topic
- Oncology